NM_001079802.2(FKTN):c.18G>C (p.Lys6Asn) AND Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Jul 14, 2021
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001563933.2

Allele description [Variation Report for NM_001079802.2(FKTN):c.18G>C (p.Lys6Asn)]

NM_001079802.2(FKTN):c.18G>C (p.Lys6Asn)

Gene:

FKTN:fukutin [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

9q31.2

Genomic location:

Preferred name:

NM_001079802.2(FKTN):c.18G>C (p.Lys6Asn)

HGVS:

NC_000009.12:g.105575050G>C
NG_008754.1:g.21921G>C
NM_001079802.2:c.18G>CMANE SELECT
NM_001198963.2:c.18G>C
NM_001351496.2:c.18G>C
NM_001351497.2:c.-150G>C
NM_001351498.2:c.18G>C
NM_001351499.2:c.-497G>C
NM_001351500.2:c.-497G>C
NM_001351501.2:c.-497G>C
NM_001351502.2:c.-497G>C
NM_006731.2:c.18G>C
NP_001073270.1:p.Lys6Asn
NP_001185892.1:p.Lys6Asn
NP_001338425.1:p.Lys6Asn
NP_001338427.1:p.Lys6Asn
NP_006722.2:p.Lys6Asn
LRG_434t1:c.18G>C
LRG_434t2:c.18G>C
LRG_434:g.21921G>C
LRG_434p2:p.Lys6Asn
NC_000009.11:g.108337331G>C
NM_001079802.1:c.18G>C
NR_147213.2:n.233G>C
NR_147214.2:n.141G>C

Protein change:

K6N

Links:

dbSNP: rs2132016533

NCBI 1000 Genomes Browser:

rs2132016533

Molecular consequence:

NM_001351497.2:c.-150G>C - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001351499.2:c.-497G>C - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001351500.2:c.-497G>C - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001351501.2:c.-497G>C - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001351502.2:c.-497G>C - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001079802.2:c.18G>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001198963.2:c.18G>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001351496.2:c.18G>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001351498.2:c.18G>C - missense variant - [Sequence Ontology: SO:0001583]
NM_006731.2:c.18G>C - missense variant - [Sequence Ontology: SO:0001583]
NR_147213.2:n.233G>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_147214.2:n.141G>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:: Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4 (MDDGB4)
Synonyms:: MUSCULAR DYSTROPHY, CONGENITAL, FKTN-RELATED; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 4
Identifiers:: MONDO: MONDO:0013156; MedGen: C2751052; OMIM: 613152

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001786992	Genome-Nilou Lab	criteria provided, single submitter (ACMG Guidelines, 2015)	Uncertain significance (Jul 14, 2021)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001786992

Genome-Nilou Lab

criteria provided, single submitter

(ACMG Guidelines, 2015)

Uncertain significance
(Jul 14, 2021)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	no	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Details of each submission

From Genome-Nilou Lab, SCV001786992.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	no	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Dec 24, 2023

ClinVar

Relating variation to medicine